Evidence map›Paper›PMID 36364103›Full record

ArticleMolecules (Basel, Switzerland)2022

Computational Studies on Selected Macrolides Active against

Biljana Arsic, Jill Barber, Ana Cikos, Manikandan Kadirvel, Emilija Kostic, Andrew J McBain, Jelena Milicevic, Angela Oates, Andrew Regan

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Drug Repurposing for Kala-Azar.Pharmaceutics · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Biljana ArsicDivision of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.
Jill BarberDivision of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.ORCID 0000-0002-5424-0291
Ana CikosNMR Centre, Ruđer Bošković Institute, Bijenička Cesta 54, 10000 Zagreb, Croatia.ORCID 0000-0001-8101-089X
Manikandan KadirvelDivision of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.ORCID 0000-0001-8450-4211
Emilija KosticFaculty of Medicine, University of Nis, Bulevar dr Zorana Djindjica 81, 18000 Nis, Serbia.
Andrew J McBainDivision of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.ORCID 0000-0002-5255-5425
Jelena MilicevicLaboratory for Bioinformatics and Computational Chemistry, Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, The University of Belgrade, Mike Petrovica Alasa 12-14, 11351 Belgrade, Serbia.ORCID 0000-0001-7783-6218
Angela OatesCentre for Biomedicine, Hull York Medical School, Faculty of Health Sciences, University of Hull, Hull HU6 7RX, UK.ORCID 0000-0003-0519-4556
Andrew ReganDepartment of Chemistry, University of Manchester, Oxford Road, Manchester M13 9PL, UK.
University of Manchester · GBUniversity of Nis · RSRuđer Bošković Institute · HRUniversity of Belgrade · RSUniversity of Hull · GB

Funding

Ministry of Education, Science and Technological Development (Republic of Serbia) 451-03-68/2022-14/200124 (B.A.); 451-03-68/2022-14/200017 (J.M.)
6 · The paper itself

Abstract

Although many antibiotics are active against Gram-positive bacteria, fewer also show activity against Gram-negative bacteria. Here, we present a combination of in silico (electron ion-interaction potential, molecular docking, ADMET), NMR, and microbiological investigations of selected macrolides (14-membered, 15-membered, and 16-membered), aiming to discover the pattern of design for macrolides active against Gram-negative bacteria. Although the conformational studies of 14-membered and 15-membered macrolides are abundant in the literature, 16-membered macrolides, and their most prominent representative tylosin A, have received relatively little research attention. We therefore report the complete

Indexed as

MacrolidesTylosinAnti-Bacterial AgentsChloroformEscherichia coliGram-Negative BacteriaGram-Positive BacteriaMolecular Docking SimulationAnti-Bacterial AgentsChloroformMacrolidesTylosin2D ROESY NMRbacteriamacrolides

Identifiers

PMID36364103
PMCPMC9654277
OpenAlexW4307547533

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.